PROTAGONIST THERAPEUTICS, INC. (PTGX) Revenue 2017–2025
PROTAGONIST THERAPEUTICS, INC. (PTGX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$46.0MFY2025 · since FY2017: $20.1M → $46.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $46.0M | -89.4% |
| FY2024 | $434.4M | +624.1% |
| FY2023 | $60.0M | +125.7% |
| FY2022 | $26.6M | -2.8% |
| FY2021 | $27.4M | -4.4% |
| FY2020 | $28.6M | +12293.1% |
| FY2019 | $231,000 | -99.3% |
| FY2018 | $30.9M | +54.1% |
| FY2017 | $20.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice